GR3006613T3 - - Google Patents

Info

Publication number
GR3006613T3
GR3006613T3 GR920403024T GR920403024T GR3006613T3 GR 3006613 T3 GR3006613 T3 GR 3006613T3 GR 920403024 T GR920403024 T GR 920403024T GR 920403024 T GR920403024 T GR 920403024T GR 3006613 T3 GR3006613 T3 GR 3006613T3
Authority
GR
Greece
Prior art keywords
polysaccharides
staphylococcus aureus
capsule
coagulase
preparation
Prior art date
Application number
GR920403024T
Other languages
Greek (el)
English (en)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of GR3006613T3 publication Critical patent/GR3006613T3/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C12P19/04—Polysaccharides, i.e. compounds containing more than five saccharide radicals attached to each other by glycosidic bonds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/085—Staphylococcus
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • C12Q1/04—Determining presence or kind of microorganism; Use of selective media for testing antibiotics or bacteriocides; Compositions containing a chemical indicator therefor
    • C12Q1/14—Streptococcus; Staphylococcus
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/195—Assays involving biological materials from specific organisms or of a specific nature from bacteria
    • G01N2333/305—Assays involving biological materials from specific organisms or of a specific nature from bacteria from Micrococcaceae (F)
    • G01N2333/31—Assays involving biological materials from specific organisms or of a specific nature from bacteria from Micrococcaceae (F) from Staphylococcus (G)
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/822—Microorganisms using bacteria or actinomycetales
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/822—Microorganisms using bacteria or actinomycetales
    • Y10S435/882—Staphylococcus
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/822—Microorganisms using bacteria or actinomycetales
    • Y10S435/882—Staphylococcus
    • Y10S435/883—Staphylococcus aureus

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Toxicology (AREA)
  • Medicinal Chemistry (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Analytical Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Saccharide Compounds (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
  • Medicinal Preparation (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GR920403024T 1987-08-03 1992-12-21 GR3006613T3 (enExample)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8711006A FR2619122B1 (fr) 1987-08-03 1987-08-03 Procede d'obtention de polyosides capsulaires de staphylocoques, polyosides obtenus, applications de ces polyosides et souches pour la mise en oeuvre du procede

Publications (1)

Publication Number Publication Date
GR3006613T3 true GR3006613T3 (enExample) 1993-06-30

Family

ID=9353830

Family Applications (1)

Application Number Title Priority Date Filing Date
GR920403024T GR3006613T3 (enExample) 1987-08-03 1992-12-21

Country Status (11)

Country Link
US (1) US4902616A (enExample)
EP (1) EP0302781B1 (enExample)
JP (1) JPH01128793A (enExample)
AT (1) ATE82134T1 (enExample)
CA (1) CA1320466C (enExample)
DE (1) DE3875850T2 (enExample)
DK (1) DK173564B1 (enExample)
ES (1) ES2052759T3 (enExample)
FR (1) FR2619122B1 (enExample)
GR (1) GR3006613T3 (enExample)
PT (1) PT88166B (enExample)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5055455A (en) 1988-09-28 1991-10-08 Brigham And Women's Hospital Capsular polysaccharide adhesin antigen, preparation, purification and use
GB8906794D0 (en) * 1989-03-23 1989-05-10 Carroll Noel Preparation of vaccines
US7279162B1 (en) * 1990-10-22 2007-10-09 Henry M. Jackson Foundation For The Advancement Of Military Medicine Isolated broadly reactive opsonic immunoglobulin for treating a pathogenic coagulase-negative staphylococcus infection
AU681573B2 (en) * 1991-11-22 1997-09-04 Glaxosmithkline Biologicals Sa Type I and type II surface antigens associated with (staphylococcus epidermidis)
US5770208A (en) * 1996-09-11 1998-06-23 Nabi Staphylococcus aureus B-linked hexosamine antigen
US5837482A (en) * 1997-01-23 1998-11-17 Minnesota Mining And Manufacturing Company Culture medium and methods for detecting staphylococci
US6610293B1 (en) 1997-06-16 2003-08-26 The Henry M. Jackson Foundation For The Advancement Of Military Medicine Opsonic and protective monoclonal and chimeric antibodies specific for lipoteichoic acid of gram positive bacteria
US7250494B2 (en) * 1998-06-15 2007-07-31 Biosynexus Incorporated Opsonic monoclonal and chimeric antibodies specific for lipoteichoic acid of Gram positive bacteria
US7252828B2 (en) 1998-07-15 2007-08-07 The Brigham And Women's Hospital, Inc. Polysaccharide vaccine for staphylococcal infections
EP1967203A1 (en) * 1998-07-15 2008-09-10 The Brigham and Women's Hospital Polysaccharide vaccine for staphylococcal infections
US20020092987A1 (en) * 1998-09-05 2002-07-18 Taehee Cho Photo detect device using quantum dots and materialization method thereof
US6936258B1 (en) * 1999-03-19 2005-08-30 Nabi Biopharmaceuticals Staphylococcus antigen and vaccine
US7119172B2 (en) * 2001-05-21 2006-10-10 The Brigham And Women's Hospital, Inc. P. aeruginosa mucoid exopolysaccharide specific binding peptides
US6962813B2 (en) * 2001-05-21 2005-11-08 The Brigham And Women's Hospital, Inc. P. aeruginosa mucoid exopolysaccharide specific binding peptides
US7723087B2 (en) 2002-11-12 2010-05-25 The Brigham And Women's Hospital, Inc. Nucleic acid molecules for enhanced production of a bacterial polysaccharide and methods of use thereof
PT1565478T (pt) 2002-11-12 2017-11-14 The Brigham And Women`S Hospital Inc Vacina de polissacáridos para infeções estafilocócicas
CN1922489A (zh) * 2003-12-30 2007-02-28 3M创新有限公司 葡萄球菌的检测
US7399609B2 (en) * 2003-12-30 2008-07-15 3M Innovative Properties Company Staphylococcus detection
JP5080243B2 (ja) 2004-04-21 2012-11-21 ザ ブライハム アンド ウイメンズ ホスピタル， インコーポレイテッド ポリ−Ｎ−アセチルグルコサミン（ＰＮＡＧ／ｄＰＮＡＧ）結合ペプチドおよびその使用方法
AU2005286694A1 (en) * 2004-09-21 2006-03-30 The Brigham And Women's Hospital, Inc. Methods and compositions relating to mannuronic acid specific binding peptides
JP5658564B2 (ja) * 2007-08-31 2015-01-28 ザ・ユニバーシティ・オブ・シカゴＴｈｅ Ｕｎｉｖｅｒｓｉｔｙ Ｏｆ Ｃｈｉｃａｇｏ ブドウ球菌肺疾患および状態に対する免疫に関連した方法および組成物
US9181329B2 (en) 2007-08-31 2015-11-10 The University Of Chicago Methods and compositions related to immunizing against Staphylococcal lung diseases and conditions
KR101573648B1 (ko) 2008-07-21 2015-12-01 더 브리검 앤드 우먼즈 하스피털, 인크. 합성 베타-1,6 글루코사민 올리고당에 관한 방법 및 조성물
WO2010014304A1 (en) * 2008-07-29 2010-02-04 University Of Chicago Compositions and methods related to staphylococcal bacterium proteins
HUE026855T2 (en) 2009-04-03 2016-07-28 Univ Chicago Compositions and methods related to protein a (spa) variants
SG186290A1 (en) 2010-07-02 2013-01-30 Univ Chicago Compositions and methods related to protein a (spa) variants
BR112013024322B1 (pt) * 2011-03-22 2020-04-22 Serum Inst India Ltd processo para preparação de polissacarídeos
US8945588B2 (en) 2011-05-06 2015-02-03 The University Of Chicago Methods and compositions involving protective staphylococcal antigens, such as EBH polypeptides
US12397014B2 (en) 2019-02-05 2025-08-26 The Brigham And Women's Hospital, Inc. Polysaccharide compositions for use in treating filariasis

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4123520A (en) * 1977-08-01 1978-10-31 Merck & Co., Inc. Method for preparing high molecular weight meningococcal Group C vaccine
JPS5452794A (en) * 1977-09-30 1979-04-25 Kousaku Yoshida Extracting of polysacchride from capusle containing epidermis staphylococus
US4221906A (en) * 1979-03-19 1980-09-09 American Cyanamid Company Stabilization of pneumococcal polysaccharides
FR2475900A1 (fr) * 1980-02-20 1981-08-21 Fabre Sa Pierre Complexe vaccinal contenant un antigene specifique et vaccin le contenant

Also Published As

Publication number Publication date
EP0302781B1 (fr) 1992-11-11
JPH01128793A (ja) 1989-05-22
US4902616A (en) 1990-02-20
ATE82134T1 (de) 1992-11-15
DK173564B1 (da) 2001-03-12
PT88166B (pt) 1995-07-03
FR2619122B1 (fr) 1990-03-09
DE3875850D1 (de) 1992-12-17
DE3875850T2 (de) 1993-06-09
FR2619122A1 (fr) 1989-02-10
EP0302781A1 (fr) 1989-02-08
PT88166A (pt) 1989-06-30
ES2052759T3 (es) 1994-07-16
DK433488A (da) 1989-02-04
CA1320466C (en) 1993-07-20
DK433488D0 (da) 1988-08-03

Similar Documents

Publication Publication Date Title
GR3006613T3 (enExample)
PL241175A1 (en) Process for preparing novel quaternary 6,11-dihydro-dibenzo-/b,e/-thiepine-11-n-alkylnorskopinethers
ES520259A0 (es) Un procedimiento para preparar un complejo inmunogeno no covalentes de polisacarido-proteina, y obtenido a partir de capsulas bacterianas.
DE2963863D1 (en) Chitin derivative, material comprising said derivative and process for the preparation thereof
AU2851592A (en) A process for the preparation of 2-acetyl-1-pyrroline in encapsulated form, the intermediate compound and end product obtained
IT7821336A0 (it) Pseudo-trissaccaridi, procedimenti per la loro preparazione e loro impiego come prodotti medicinali.
DE2961091D1 (en) E. coli enterotoxin vaccine for veterinary & human use and process for its preparation
AU535804B2 (en) Influenza vaccine production
AU542902B2 (en) Substituted carboxylic ceto-acids, process for the preparation thereof, use thereof and medicinal compositions containing them
AU462340B2 (en) N-(dimethylamino-methylidene)-thiol(thiono)-phosphoric acid ester imides, process for their preparation, and their use as insecticides or acaricides
EP0268996A3 (en) Lactonic degradation product, process for its preparation and its use
NL7703753A (nl) Werkwijze ter bereiding van een antitumorigeen antibioticum, en gevormd geneesmiddel, evenals werkwijze ter bereiding van de actieve verbin- ding.
IT7828782A0 (it) Antibiotici, loro preparazione eloro impiego come prodotti antimicrobici.
IT1147016B (it) Procedimento per la produzione di 7-alcossicarbonil-6,8-dimetil-4-idrossimetil-1-ftalazone e relativi prodotti intermedi
IL57501A (en) Antibiotics s-54832-a-i-a-iv,their production by cultivating micromonosporia strain and pharmaceutical compositions containing them
IT7827564A0 (it) 1,4-di-idro-piridazine, procedimento per la loro preparazione e loro impiego come prodotti medicinali.
PT71484A (en) Process for the preparation of an insecticidal compositioncontaining esters of n,n-dimethyl-o-pyrimidinyl-carbamic acids
CA936869A (en) 2-acylamino-1,3,4-thiadiazole-(thi)ones-(5), process for their preparation and their use as herbicides
EG14295A (en) N-oximinoalkyl-anilides,process for their preparation and their use as fungicides
IT7830115A0 (it) Diclorovinil-ciclobutanoni, procedimento per la loro preparazione e loro impiego come prodotti intermedi per la prepazione di prodotti disinfestanti.
DE3060958D1 (en) 2-phenyl-4-pyrone derivatives, process for their preparation and their use as fungicides
DE3060695D1 (en) Fluorinated 1-imidazolyl-butane derivatives, process for their preparation and their application as fungicides
ZA801426B (en) Isoindoiline derivative, a process for its preparation, and therapeutic compositions which containt it as the active principle
IT7828537A0 (it) 1. 4-idro-piridazine 1-n-sostituite, procedimento per la loro preparazione e loro impiegocome prodotti medicinali.
IE33922B1 (en) Improvements in and relating to vaccines